These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 24866422)
1. The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity. Brakoulias V Expert Opin Pharmacother; 2014 Jul; 15(10):1321-3. PubMed ID: 24866422 [TBL] [Abstract][Full Text] [Related]
2. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders]. Nakamae T Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889 [TBL] [Abstract][Full Text] [Related]
12. Do all obsessive-compulsive disorder subtypes respond to medication? Grados M; Riddle MA Int Rev Psychiatry; 2008 Apr; 20(2):189-93. PubMed ID: 18386211 [TBL] [Abstract][Full Text] [Related]
13. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series. Weiss EL; Potenza MN; McDougle CJ; Epperson CN J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634 [TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approach. Uguz F Braz J Psychiatry; 2015; 37(4):334-42. PubMed ID: 26692431 [TBL] [Abstract][Full Text] [Related]
16. A systematic review of the use of risperidone, paliperidone and aripiprazole as augmenting agents for obsessive-compulsive disorder. Brakoulias V; Stockings E Expert Opin Pharmacother; 2019 Jan; 20(1):47-53. PubMed ID: 30360669 [TBL] [Abstract][Full Text] [Related]
18. A review of antipsychotics in the treatment of obsessive compulsive disorder. Fineberg NA; Gale TM; Sivakumaran T J Psychopharmacol; 2006 Jan; 20(1):97-103. PubMed ID: 16204331 [No Abstract] [Full Text] [Related]
19. [Pharmacological treatments for obsessive-compulsive disorder and the serotonin-dopamine hypothesis]. Okamoto Y Seishin Shinkeigaku Zasshi; 2011; 113(1):36-44. PubMed ID: 21404630 [TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]